content top

MH After Intravitreal Ranibizumab Injection for DME

Poster Jaeryung Oh Purpose: To report a case of macular hole formed after intravitreal ranibizumab injection in diabetic macular edema. Case summary: A 76-year-old woman with a 30-year history of type 2 diabetes visited the clinic presenting with the complaint of decreased vision in her right eye. The best-corrected visual acuity of the right eye was 6/20, and 6/12 in the left eye. Intraocular pressure was 20 mmHg in her right eye and she...

Read More

Expression Pattern of Extracellular Matrix Components After Ranibizumab for Neovascular ARMD

Poster Malgorzata Nita Purpose: The aim of the study was to evaluate the effect of loading doses of ranibizumab on gene expression of matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs) in patients with CNV/AMD. Setting: Study was conducted by the Department of Ophthalmology, Medical University of Silesia, Independent Public Clinical Hospital, Katowice, Poland. Methods Inclusion criteria: patients ≥60...

Read More

Three Consecutive Loading Dose of Ranibizumab for the Treatment of Retinal Angiomatous Proliferation

Purpose: To evaluate the 12 months functional outcome and morphological changes according stages after 3 monthly intravitreal ranibizumab injections for the treatment of retinal angiomatous proliferation (RAP) in Korea. Methods: A retrospective chart review of 40 patients (41 eyes) with RAP was conducted. Patients received three initial monthly intravitreal injections (0.5 mg) of ranibizumab and monitored monthly for 12 months....

Read More

3 Cases of MH Following Intravitreal Injection with Ranibizumab

Poster Youngduk Kim Purpose: To report three cases of macular hole formation in patients who was administered intravitreal ranibizumab. Method: The first case was a 72-year-old man with age related macular degeneration and vitreomacular adhesion. The second case was a 76-year-old woman with subretinal haemorrhage and high PED. She was diagnosed with ARMD. The third case was 51-year-old woman with subretinal haemorrhage and high myopia....

Read More

Ocular Adverse Events Related to Intravitreal Ranibizumab in Patients with Exudative ARMD

Purpose: Anti-VEGF injections have been standard treatment of exudative age-related macular degeneration (ARMD) in recent years. However multiple and recurrent injections needed to maintain the efficacy of the treatment may lead to adverse side effects related to this regimen. The aim of this study was to find out ocular adverse events associated with intravitreal injection of ranibizumab for the treatment of exudative ARMD performed in a...

Read More

Effect of Intravitreal Ranibizumab on Cardiac Ischemic Parameters and Vascular Endothelial Function

Poster Altan Goktas Purpose: To evaluate the effect of intravitreal ranibizumab injection on cardiac ischemic parameters and vascular endothelial function. Methods: This observational, prospective case series included a total of 48 patients (23 patients with age-related macular degeneration and 25 patients with diabetic macular edema). All participants received intravitreal injections of 0.5 mg ranibizumab. Cardiac ischemic parameters...

Read More
content top